Study of Families With an Hemopathies Predisposition Related to the DDX41 Gene.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

910 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-11-17

Study Completion Date

2030-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a multicenter, interventional, historico-prospective cohort pilot study aimed at specifying the phenotype of subjects carrying a constitutional familial DDX41 mutation, with a view to eventually publishing oncogenetic recommendations for carriers of this mutation.

The main objective of the LUCID project is to assess the cumulative risk of hematological diseases as a function of age in DDX41 germline mutation carriers.

This study will be carried out in two stages:

Stage 1: Inclusion of index cases in an oncogenetic consultation (salivary test, completion of an health self-questionnaire and collection of contact details for the related cases).

Stage 2: Proposition of participation to family members, by correspondence, and determination of carrier or non-carrier status of the constitutional familial DDX41 mutation (based on a salivary test).

A maximum of 210 index case patients and 700 family member will be included in this study.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families

NCT00230620

Telangiectasia, Hereditary Hemorrhagic

RECRUITING

Identification of Genes and Pathogenesis Involved in Familial Thoracic Aortic Aneurysm

NCT02256163

Thoracic Aortic Aneurysm

COMPLETED

Advanced Lipoproptein Profiling and Cardiovascular Risk Stratification in Familial Hypercholesterolemia

NCT05066932

Familial Hypercholesterolemia Atherosclerosis

UNKNOWN

Stratification of Arrhythmic Risk and/or Heart Failure Risk in Patients With Hereditary Heart Disease

NCT07257289

Hereditary Heart Diseases

NOT_YET_RECRUITING

Genetics of Peripheral Artery Genomics

NCT00615121

Peripheral Artery Disease

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

DDX41 Gene Mutation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Index case or related

Group Type EXPERIMENTAL

For each person (index case or related) included in this study:

Intervention Type GENETIC

* an health questionnaire will be completed in order to gather information on the participant's medical history and lifestyle.
* a saliva sample will be taken (if applicable) so that a genetic analysis can be performed.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

For each person (index case or related) included in this study:

* an health questionnaire will be completed in order to gather information on the participant's medical history and lifestyle.
* a saliva sample will be taken (if applicable) so that a genetic analysis can be performed.

Intervention Type GENETIC

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Women or man aged ≥ 18 years old.
2. Personal history(s) of hemopathy or patient with hemopathy at the time of inclusion.
3. Patient with a tumor mutation of DDX41 with an allelic frequency (AF) ≥ 30% (with total depth of nucleotide position \>300x: provide tumor molecular analysis report).

Special case of inclusion of deceased index cases: the DDX41 tumor mutation of interest must be accompanied by another somatic DDX41 mutation (the most frequent being p.R525H).

Or patient known to be a constitutional carrier of a DDX41 mutation confirmed after oncogenetic consultation (in this case, provide constitutional analysis report).
4. Patient (or beneficiary) agreeing to release results of oncogenetic report.
5. Patient (or beneficiary) agrees to communicate the contact details of his relatives and that they may be contacted by mail to participate in the LUCID study.
6. Patient affiliated to a Social Health Insurance in France.
7. Patient able to participate and willing to give informed consent prior performance of any study-related procedures.

1. Women or man aged ≥ 18 years old.
2. Related to an index case included in the LUCID study.
3. Agreeing to carry out a scientific salivary test for the constitutional research of the DDX41 mutation.
4. Patient affiliated to a Social Health Insurance in France.
5. Patient able to participate and willing to give informed consent prior performance of any study-related procedures.

Exclusion Criteria

1. No history of hemopathy or no current hemopathy.
2. Patient (or beneficiary) unable to complete questionnaire for social or psychological reasons.
3. Patient who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice).

Related cases (Family member):

1. Not applicable from version 2 of the protocol. Related in the 4th or 5th degree to an index case included in the LUCID study.
2. Person already identified as an index case in the LUCID study.
3. Person unable to complete questionnaire for social or psychological reasons.
4. Person who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice).

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes